TriSalus Life Sciences Inc
NASDAQ:TLSI
| Market Cap (Intraday) | 124.28M |
| Current PE | N/A |
| Forward PE | N/A |
| 2yr Forward PE | N/A |
| 10-Day MA | $4.35 |
| 50-Day MA | $5.01 |
| 200-Day MA | $7.51 |
TriSalus Life Sciences Inc Stock, NASDAQ:TLSI
6272 West 91st Avenue, Westminster, Colorado 80031
United States of America
Phone: +1.303.442.1222
Number of Employees: 112
Description
TriSalus Life Sciences, Inc. is an oncology company, which engages in the business of integrating standard-of-care treatments and investigational immunotherapeutic with disruptive pressure enabled drug delivery infusion systems to transform the treatment paradigm for patients battling liver and pancreatic tumors. The company was founded on September 11, 2020, and is headquartered in Westminster, CO.